世界の糖尿病治療薬市場は、2021年に約1兆3,898億3,000万米ドルと評価され、予測期間の2022年から2028年には10.40%以上の健全な成長率で成長すると予想されています。
糖尿病治療薬とは、インスリン注射、ポンプ、経口薬など、糖尿病患者の治療に利用されるさまざまな治療技術を指します。糖尿病は、膵臓からインスリンが分泌されなくなったり、分泌されたインスリンを体が十分に利用できなくなった場合に発症する慢性代謝性疾患であり、心臓に悪い影響を与える血糖値の上昇によって特徴づけられます。不健康な食事や座りっぱなしの生活による肥満が原因となって糖尿病の有病率が増加しています。また、糖尿病に対する認識を高めるために、様々な医療機関がプログラムを開始することが多くなっています。国際糖尿病連合（IDF）によると、成人（20〜79歳）の糖尿病患者数は約5億3,700万人と報告されており、2030年には6億4,300万人、2045年には7億8,300万人に増加すると予測されています。また、米国疾病対策予防センター（CDC）は、官民協力のもと、「全米糖尿病予防プログラム（National Diabetes Prevention Program：National DPP）」を開始することを発表しています。全米糖尿病予防プログラムは、2型糖尿病を予防または遅らせることを目的としています。また、ヘルスケア分野における研究開発の増加、先進的な薬剤の市場導入、新製品の承認などが、糖尿病市場の成長に寄与しています。老年人口および肥満人口の増加：Center for Aging Betterによると、2021年にはイギリスで65歳以上の高齢者が約1,200万人、80歳以上が320万人存在するため、老年人口の増加が予測期間中の市場成長を高めると思われます。しかし、抗糖尿病薬の長期使用に伴う様々な副作用が、2022年から2028年の予測期間中の市場成長を阻害しています。
糖尿病治療薬の世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは2021年に世界のインスリン治療薬市場を独占しましたが、これは同地域における座りがちなライフスタイルによる糖尿病の高い有病率と、同地域での新薬の上市に起因しています。アメリカは、同地域における肥満の高い有病率や糖尿病治療に関する意識の高まりなどの要因から、予測期間中に驚異的な成長を遂げると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Diabetes Therapeutics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Diabetes Therapeutics Market, by Product, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Diabetes Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Diabetes Therapeutics Market Dynamics
3.1. Diabetes Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of diabetes
3.1.1.2. Favourable initiatives from government authorities.
3.1.2. Market Challenges
3.1.2.1. Side effects associated with long-term use of anti-diabetes drug.
3.1.3. Market Opportunities
3.1.3.1. Growing number of R&D activities in healthcare sector
3.1.3.2. Increasing number of geriatric and obese individuals.
Chapter 4. Global Diabetes Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Diabetes Therapeutics Market, by Product
6.1. Market Snapshot
6.2. Global Diabetes Therapeutics Market by Product, Performance - Potential Analysis
6.3. Global Diabetes Therapeutics Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
6.4. Diabetes Therapeutics Market, Sub Segment Analysis
6.4.1. Injectables
6.4.2. Oral antidiabetic Drugs
Chapter 7. Global Diabetes Therapeutics Market, Regional Analysis
7.1. Diabetes Therapeutics Market, Regional Market Snapshot
7.2. North America Diabetes Therapeutics Market
7.2.1. U.S. Diabetes Therapeutics Market
7.2.1.1. Product estimates & forecasts, 2018-2028
7.2.2. Canada Diabetes Therapeutics Market
7.3. Europe Diabetes Therapeutics Market Snapshot
7.3.1. U.K. Diabetes Therapeutics Market
7.3.2. Germany Diabetes Therapeutics Market
7.3.3. France Diabetes Therapeutics Market
7.3.4. Spain Diabetes Therapeutics Market
7.3.5. Italy Diabetes Therapeutics Market
7.3.6. Rest of Europe Diabetes Therapeutics Market
7.4. Asia-Pacific Diabetes Therapeutics Market Snapshot
7.4.1. China Diabetes Therapeutics Market
7.4.2. India Diabetes Therapeutics Market
7.4.3. Japan Diabetes Therapeutics Market
7.4.4. Australia Diabetes Therapeutics Market
7.4.5. South Korea Diabetes Therapeutics Market
7.4.6. Rest of Asia Pacific Diabetes Therapeutics Market
7.5. Latin America Diabetes Therapeutics Market Snapshot
7.5.1. Brazil Diabetes Therapeutics Market
7.5.2. Mexico Diabetes Therapeutics Market
7.6. Rest of The World Diabetes Therapeutics Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Astrazenecaplc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boehringer Ingelheim Gmbh
8.2.3. Eli Lilly And Company
8.2.4. GlaxoSmithKline plc
8.2.5. Novartis AG
8.2.6. Novo Nordisk
8.2.7. Sanofi S.A
8.2.8. Takeda Pharmaceutical Company Limited
8.2.9. Johnson And Johnson MD&D
8.2.10. Merck And Co.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Diabetes Therapeutics Market, report scope
TABLE 2. Global Diabetes Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Diabetes Therapeutics Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 5. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 6. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. U.S. Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 16. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 17. Canada Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. UK Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. Germany Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. RoE Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. China Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. India Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. Japan Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. RoAPAC Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. Brazil Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Mexico Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. RoLA Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. Row Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. List of secondary sources, used in the study of global Diabetes Therapeutics Market
TABLE 54. List of primary sources, used in the study of global Diabetes Therapeutics Market
TABLE 55. Years considered for the study
TABLE 56. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Diabetes Therapeutics Market, research methodology
FIG 2. Global Diabetes Therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Diabetes Therapeutics Market, key trends 2021
FIG 5. Global Diabetes Therapeutics Market, growth prospects 2022-2028
FIG 6. Global Diabetes Therapeutics Market, porters 5 force model
FIG 7. Global Diabetes Therapeutics Market, pest analysis
FIG 8. Global Diabetes Therapeutics Market, value chain analysis
FIG 9. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Diabetes Therapeutics Market, regional snapshot 2018 & 2028
FIG 15. North America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
FIG 16. Europe Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific market 2018 & 2028 (USD Billion)
FIG 18. Latin America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
FIG 19. Global Diabetes Therapeutics Market, company market share analysis (2021)
